エピソード

  • Stop Borrowing Energy From Tomorrow: The Science of Ergothioneine + Ginseng + Rhodiola

    Stop Borrowing Energy From Tomorrow: The Science of Ergothioneine + Ginseng + Rhodiola
    2026/02/26
    Most “energy” products are just caffeine in disguise — a short-term loan with a brutal crash. In this Deep Dive, we go beyond stimulation and into real cellular energy by decoding a three-compound “energy code” found inside BioElixir MIND: Ergothioneine (EGT), Panax ginseng, and Rhodiola rosea. You’ll learn why EGT is called a “longevity vitamin” (and how it outperforms major antioxidants in lab testing), how the body uses a dedicated transporter (OCTN1) to deliver it into high-risk tissues like the eyes and brain, and why EGT’s stability matters in the real world. Then we shift to Panax ginseng and its surprising links to telomere length and a more youthful NAD⁺/NADH ratio, plus human-reported improvements in sleep, fatigue, cognition, and sexual health. Finally, we break down Rhodiola as a true adaptogen — less “stimulant,” more thermostat — supporting stress resilience, mood, and focus while keeping the cardiovascular system steady. If you’re tired of “wash the windshield” advice, this is the episode that talks about fixing the engine. (Educational content only, not medical advice.) - Articles Discussed in Episode: Ergothioneine: Evaluation of a Novel Antioxidant for Targeting Ocular Oxidative Stress Panax ginseng Meyer supplementation and potential associations with telomere length and NAD+/NADH ratio in middle-aged adults: An exploratory study Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases - Key Quotes From Dr. Mike: “Most ‘energy’ isn’t energy — it’s borrowing from tomorrow.” “EGT isn’t just strong in a test tube — your body built a VIP entrance specifically to pull it into cells.” “EGT doesn’t just clean up oxidative stress — it helps prevent new damage from forming.” “Ginseng didn’t just change how people felt — it moved biomarkers tied to biological aging.” “Rhodiola isn’t a gas pedal. It’s cruise control.” “Shield, repair, resilience — that’s the real energy code.” - Key points Caffeine ≠ energy: it’s “borrowing energy from tomorrow” with interest. The “Energy Trinity”: EGT (shield) + Panax ginseng (restore) + Rhodiola (resilience). EGT’s standout potency: extreme free-radical scavenging in standardized assays vs common antioxidants. EGT targets the worst offenders: especially hydroxyl radicals and hypochlorous acid. Metal chelation matters: EGT binds free iron/copper to reduce radical formation (prevention, not just cleanup). Bioavailability solved: the body has a dedicated EGT transporter (OCTN1)—a built-in “VIP door.” High-value delivery zones: OCTN1 is highly expressed in the retina/cornea and brain. Real penetration evidence: ocular model shows EGT reaching the back of the eye quickly after topical use. EGT is unusually stable: retains potency under heat/humidity—rare for antioxidants. Ginseng & aging markers: associated with telomere elongation and improved NAD⁺/NADH ratio in humans. Rhodiola = thermostat: improves stress resilience and mental stamina without the jittery stimulant profile. Timing matters: Rhodiola is best earlier in the day to avoid sleep disruption. - Episode timeline 0:19–1:40 – Why modern “energy” is mostly caffeine + maintenance-level advice 1:40–3:45 – The thesis: 3 molecules that unlock cellular energy (and how they map to BioElixir MIND) 4:18–17:35 – Ergothioneine (EGT): potency, what it targets, metal chelation, OCTN1 “VIP transporter,” ocular penetration, and stability 17:38–26:15 – Panax ginseng: telomeres, NAD⁺/NADH ratio, and reported improvements (sleep, fatigue, cognition, sexual health) 26:22–32:20 – Rhodiola rosea: adaptogen definition, stress resilience, neurotransmitter support, calm-focus effect, best timing 32:57–end – The synthesis: EGT = shield, ginseng = restoration, rhodiola = resilience - ⚡ BioElixir MIND: Shield • Restore • Resilience ⚡ BioElixir MIND is built for real cellular energy, not a jittery stimulant spike. Inspired by today’s Deep Dive, it combines ergothioneine (EGT) to help defend high-demand tissues from oxidative stress, Panax ginseng to support the body’s energy and aging architecture (think NAD⁺ balance and cellular renewal), and Rhodiola rosea for calm, steady resilience under stress. BioElixir MIND also incorporates Alpha-GPC + Citicoline, PQQ, Acetyl-L-Carnitine and Shilajit. The result? Smooth cognitive performance without the harsh spikes and crashes. If coffee feels like a loan with interest, MIND is the upgrade: shield the system, restore the engine, and stay sharp without the crash. Clarity isn’t accidental. It’s engineered. Save 15% off your order of BioElixir MIND! Discount code: MIND15 Expires on 3/4, midnight PST *Must use "Single" quantity option; code will not work for 2-, 4- or 10-pack quantity options. Shop BioElixir ...
    続きを読む 一部表示
    34 分
  • Did Your Dad Contribute to Your Mitochondria? The “Spare Tire” Theory That Could Rewrite Biology

    Did Your Dad Contribute to Your Mitochondria? The “Spare Tire” Theory That Could Rewrite Biology
    2026/02/25
    In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a 2025 review in Mitochondrion that challenges one of biology’s most entrenched rules: the idea that mitochondrial DNA is inherited only from the mother. For decades, paternal mitochondria were considered disposable “damaged goods” — actively destroyed by the egg through highly conserved cellular cleanup systems. But this episode explores mounting evidence that the rule may be more flexible than we thought, especially under crisis conditions. The hosts break down: why biology usually enforces maternal-only mitochondrial inheritance, how paternal mitochondria are normally eliminated, the controversy over “paternal leakage” and human case reports, why NUMTs (nuclear mitochondrial DNA fossils) created years of scientific confusion, and the breakthrough 2024 fruit fly study that provided functional proof of paternal mitochondrial rescue. Their central takeaway is a powerful new idea: paternal mitochondrial inheritance may not be random leakage at all — it may be a built-in evolutionary fail-safe, a cellular “spare tire” activated only when the mother’s mitochondria fail. This episode reframes biology not as a system of rigid laws, but as a dynamic intelligence built for survival. (Educational content only, not medical advice.) - Article Discussed in Episode: Research progress on paternal mitochondrial inheritance: An overview - Key Quotes From Dr. Mike: “This idea of maternal inheritance has been treated like an absolute law.” “The old rule was simple: dad gives nuclear DNA, mom gives the mitochondria. This paper says the story may be more flexible than that.” “The cell doesn’t reject paternal mitochondria just because they’re from dad — it rejects them because mixing mitochondrial code can create chaos.” “The ‘spare tire’ theory is simple: a damaged backup is still better than no energy at all.” “The cell may be willing to break its own inheritance rules if that’s what it takes to keep ATP flowing and keep life alive.” - Key points The episode challenges a core biology rule: mtDNA may not be strictly maternal in all cases. A 2025 review suggests paternal mtDNA inheritance can occur in crisis conditions. This matters for disease diagnosis, evolution, and metabolic biology. Maternal-only inheritance helps avoid heteroplasmy (conflicting mitochondrial DNA populations). Eggs dominate mtDNA by numbers (huge mtDNA load vs. very few in sperm). Sperm mitochondria are essential for motility but often arrive oxidatively stressed (“damaged goods”). Cells actively destroy paternal mitochondria using robust cleanup pathways (autophagy, ubiquitination, etc.). Rare “paternal leakage” signals were seen for years but often dismissed as anomalies. A 2002 human case showed paternal mtDNA can persist and contribute to disease. The 2018 Luo study reignited the field by reporting biparental inheritance in multiple families. NUMTs complicated the debate because they can mimic mtDNA in standard sequencing. A 2024 fruit fly study provided functional proof of paternal mitochondrial rescue. The key breakthrough: offspring survived despite failed maternal mitochondria, implying functional paternal mitochondria. This supports a “Spare Tire Theory” — paternal mitochondria may act as an emergency backup. The cell may accept heteroplasmy risk to avoid total energy failure. Surviving offspring showed restored mitochondrial function (including Complex I activity). The signaling mechanism is still unknown (how the egg decides to spare paternal mitochondria). This could reshape mitochondrial disease treatment by activating a natural rescue pathway. The idea is to trigger an existing backup system, not invent a new one. Big takeaway: biology may be full of hidden “backup plans” that activate under stress. - Episode timeline 0:19–1:20 — Intro + premise: a “biology law” may be breaking (maternal-only mitochondrial inheritance). 1:20–3:12 — Why it matters: impacts mitochondrial disease, evolution, and metabolic biology. 3:12–5:03 — Standard dogma: mtDNA is maternal to avoid heteroplasmy; egg vs. sperm mtDNA numbers. 5:03–6:30 — Why sperm still carry mitochondria: needed for motility, but often oxidatively damaged. 6:30–8:55 — “Demolition crew” mechanisms: how cells destroy paternal mitochondria (autophagy, ubiquitination, etc.). 8:55–10:31 — Early anomalies: paternal leakage and the 2002 human case of paternal mtDNA persistence. 10:31–13:21 — 2018 Luo study + controversy: biparental inheritance claim vs. NUMT sequencing confounders. 13:21–15:33 — 2024 fruit fly breakthrough: functional proof paternal mitochondria can rescue offspring. 15:33–17:34 — “Spare Tire Theory”: paternal mitochondria as an emergency backup when maternal mitochondria fail. 17:34–18:21 — Open question: how the egg senses failure and ...
    続きを読む 一部表示
    24 分
  • Cancer’s Hidden Engine Room: How Tumors Hijack Mitochondria to Grow, Spread, and Survive

    Cancer’s Hidden Engine Room: How Tumors Hijack Mitochondria to Grow, Spread, and Survive
    2026/02/24
    In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a striking 2025 paper by Liu and colleagues on gastrointestinal cancers (especially gastric and colorectal tumors) and why we may be looking in the wrong place for answers. Instead of focusing only on DNA mutations, this episode explores the mitochondria as the cell’s decision-makers; the organelles that help determine whether a cell grows, rests, or dies. The hosts break down the paper’s framework of mitochondrial quality control (MQC) into three core pillars: biogenesis (make), dynamics (shape), and mitophagy(break/recycle). They explain how tumors hijack these systems to fuel growth, metastasis, and drug resistance — and how therapies may work by disrupting the cancer cell’s energy code, not just damaging DNA. The conversation also covers PGC-1α, fission/fusion proteins, mitophagy under hypoxia, chemo resistance, and a fascinating (and very weird) malaria-related finding that reinforces the core concept. The big takeaway: cancer may be less about a broken blueprint and more about a corrupted energy system. (Educational content only, not medical advice.) - Article Discussed in Episode: The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors - Key Quotes From Dr. Mike: “There is no one-size-fits-all energy code.” “Cancer isn’t just a genetic accident, it’s a fundamental corruption of how the cell handles energy.” “The shape of the mitochondria literally determines how well chemotherapy works.” “Cancer operates in a Goldilocks zone.” “Proton beam therapy… also works by hacking the energy code.” - Key points GI cancers remain a massive global burden The episode opens with sobering numbers: millions of new GI tumor cases and deaths annually.Focus is specifically on gastric and colorectal cancers. The paper shifts focus from DNA to mitochondria Modern oncology often centers on mutations.This review argues mitochondria are not just “batteries” — they are decision-makers controlling cell fate. Cancer is framed as a corruption of the “energy code” The hosts describe tumors as hijacking mitochondrial decision-making.Cancer rewrites the systems that regulate growth, dormancy, and apoptosis. Mitochondrial Quality Control (MQC) is the core framework The paper’s model has three pillars: Biogenesis (making mitochondria)Dynamics (shaping mitochondria via fission/fusion)Mitophagy (recycling damaged mitochondria) The hosts summarize this as: “make, shape, and break.” Pillar 1: Biogenesis fuels tumor growth Tumors need energy to expand, so they ramp up mitochondrial production.PGC-1α is presented as the key “foreman” regulating this process. Cancer operates in a biogenesis Goldilocks zone Some biogenesis is necessary for tumor growth.But too much PGC-1α can push cells into apoptosis (cell death), making it a fragile balance. Excess biogenesis can become toxic to cancer Overproduction of mitochondria can trigger death pathways (via BAX/Bak-type mitochondrial apoptosis signaling, as described in the transcript).This creates a therapeutic opportunity: push tumor energy systems beyond their tolerance. Tumors actively silence genes that would normalize metabolism The episode describes a gastric cancer example where a gene is silenced/methylated to preserve the tumor’s metabolic advantage (including the Warburg effect dynamics). Proton beam therapy may work partly by disrupting mitochondrial balance The hosts note a non-obvious mechanism:Beyond DNA damage, proton therapy may force excess mitochondrial biogenesis and push tumors into collapse. Pillar 2: Mitochondrial dynamics = shape-shifting for survival Mitochondria constantly undergo: Fission (splitting)Fusion (merging) This is described with a “lava lamp” analogy. Fission supports metastasis Fragmented mitochondria are easier to move within the cell.Cancer uses this to bring energy to the “leading edge” during invasion and spread. Fusion/fission proteins are strategic levers The episode highlights: DRP1 (fission)MFN1, MFN2, OPA1 (fusion) Aggressive tumors exploit these pathways to support mobility and growth. Chemo resistance is partly an energy-grid strategy In Adriamycin-resistant cells, tumors increase fission and reduce fusion.By breaking mitochondrial networks into “islands,” they quarantine damage and survive drug stress. Mitochondrial shape influences chemotherapy effectiveness The episode emphasizes that mitochondrial structure is not cosmetic — it changes treatment response.The “energy grid” layout can determine whether toxicity spreads or is contained. Pillar 3: Mitophagy = recycling damaged engines Mitophagy is a mitochondria-specific form of autophagy.In healthy cells, it’s protective quality control (e.g., PINK1/Parkin pathway). Tumors weaponize mitophagy under stress In nutrient-poor or hypoxic tumor cores, cancer ramps up mitophagy to recycle parts and ...
    続きを読む 一部表示
    20 分
  • Aging Is a Civil War: How Your Telomeres and Mitochondria Fight Each Other

    Aging Is a Civil War: How Your Telomeres and Mitochondria Fight Each Other
    2026/02/23
    In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey unpack a powerful new model of aging: it’s not just “wear and tear” — it’s a communication breakdown between two core systems in the cell: telomeres (the clock) and mitochondria (the engine). Based on a recent review in the International Journal of Molecular Sciences, this episode explores how these two longevity pillars are deeply linked through oxidative stress, telomerase (TERT), and the p53 pathway. The hosts explain how damaged telomeres can shut down mitochondrial biogenesis, how dysfunctional mitochondria accelerate telomere erosion, and why this feedback loop drives cellular senescence, immune aging, and tissue decline. They also dive into the “TERT commuting” phenomenon (telomerase moving into mitochondria), the role of ROS in damaging guanine-rich telomeres, the rise of “zombie cells,” extracellular citrate as a possible future aging biomarker, and the biggest twist of all: why sperm cells seem to bend the rules of aging — and how cancer hijacks the same system. This is a big-picture episode about aging, metabolism, and longevity strategy: if you want to protect your DNA, you have to protect your mitochondria. (Educational content only, not medical advice.) - Article Discussed in Episode: Exploring the Link Between Telomeres and Mitochondria: Mechanisms and Implications in Different Cell Types - Key Quotes From Dr. Mike: “Aging isn’t just parts breaking down in isolation. It’s a communication breakdown.” “The clock breaks the engine, and the engine breaks the clock.” “TERT isn’t just for making you live longer by lengthening telomeres… it’s trying to keep the power on too.” “Biology prioritizes safety over repair.” “If you wanna protect your DNA, your telomeres — you have to protect your mitochondria.” - Key points Aging is framed as a communication breakdown, not just mechanical wear The episode challenges the “slow breakdown” model of aging.Instead, aging is described as a cellular civil war between telomeres and mitochondria. The paper links two traditionally separate longevity domains Telomere biology and mitochondrial biology are often studied independently.This review argues they are part of the same core aging system. Telomeres are the cell’s “clock” Telomeres protect chromosome ends like shoelace tips.They shorten with cell division (Hayflick limit), eventually triggering senescence. Mitochondria are the cell’s “engine” They generate ATP but also produce ROS (reactive oxygen species) as metabolic exhaust.Small ROS = signaling; too much ROS = oxidative damage. TERT isn’t only nuclear — it also goes into mitochondria A major insight from the episode: ~10–20% of TERT can localize to mitochondria.Under mild stress, the cell sends TERT to mitochondria as a protective shield against ROS damage. The “axis of aging”: short telomeres trigger a p53 shutdown cascade Critically short/damaged telomeres activate DNA damage response (DDR).This activates p53, which prioritizes safety (anti-cancer control) over repair. p53 suppresses mitochondrial renewal p53 represses PGC-1α / PGC-1β (mitochondrial biogenesis regulators).It also suppresses SIRT1, worsening metabolic decline.The result: fewer new mitochondria, failing old mitochondria, and cellular senescence. Mitochondria can “break the clock” too Dysfunctional mitochondria leak excess ROS.ROS preferentially damages guanine-rich telomeric DNA, accelerating telomere shortening. Why telomeres are especially vulnerable to oxidative stress Telomeres are rich in guanine (G), which has low redox potential (“rusts easily”).ROS oxidizes guanine into 8-oxo-dG, impairing replication and telomere integrity. This creates a vicious cycle (death spiral) Mitochondrial dysfunction → ROS → telomere damage → p53 activation → mitochondrial shutdown.The cell becomes trapped in senescence. Immune aging is a real-world example of this loop T cells need massive ATP to proliferate during infection.In older adults, shortened telomeres and p53 signaling impair mitochondrial function.This contributes to immunosenescence (weaker immune response with age). Skin aging also reflects the telomere-mitochondria link Fibroblasts under UV/oxidative stress show faster telomere shortening.Even without rapid division, poor metabolism can age tissue faster. PBM/red light therapy is framed as a “genome protection” strategy The hosts connect photobiomodulation (PBM) to improved mitochondrial efficiency and lower ROS.Their argument: better mitochondrial function may help protect telomeres indirectly by reducing oxidative stress. Senescent cells undergo metabolic reprogramming They shift from oxidative phosphorylation (OXPHOS) to glycolysis.This is less efficient and leads to metabolite buildup, especially citrate. Extracellular citrate may be a future aging biomarker Senescent cells can dump citrate outside the cell (“...
    続きを読む 一部表示
    28 分
  • Fertility After 40: Can Red & Near-Infrared Light “Recharge” Egg Quality?

    Fertility After 40: Can Red & Near-Infrared Light “Recharge” Egg Quality?
    2026/02/22
    In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey challenge one of the biggest assumptions in reproductive health: that age-related infertility is only about “running out of time.” Instead, they explore a bold idea from a 2024 case series—what if the deeper issue is running out of cellular energy? This episode unpacks a study on multi-wavelength red and near-infrared photobiomodulation (PBM) used in women ages 40–43 with difficult fertility histories, including failed IVF cycles and miscarriages. The hosts explain why the egg cell is the most mitochondria-dense cell in the body, how mitochondrial decline affects egg quality and chromosomal accuracy, and how PBM may help by boosting ATP production, improving blood flow, reducing inflammation, and supporting the reproductive environment. They also break down the surprisingly systemic treatment protocol (abdomen, lower back, neck, lymph, gut), why multi-wavelength light matters for tissue depth, and the three case outcomes that make this paper so compelling: 3 women treated, 3 live births. The big takeaway: fertility may not just be a hormonal “software” issue, it may be a mitochondrial hardware and energy issue. (Educational content only, not medical advice.) - Article Discussed in Episode: The Efficacy of Multiwavelength Red and Near-Infrared Transdermal Photobiomodulation Light Therapy in Enhancing Female Fertility Outcomes and Improving Reproductive Health: A Prospective Case Series with 9-Month Follow-Up - Key Quotes From Dr. Mike: “What if the problem isn’t that women are running out of time? What if the problem is simply that they’re running out of energy?” “If you could fix that energy problem, you might just be able to rewrite the entire code on fertility.” “The human oocyte contains more mitochondria than any other cell in the body.” “You are literally recharging the biological battery of the egg.” “If you only used red light, you’d be treating the skin, but totally missing the engine room.” “Perhaps the future of fertility… is simply about turning on the light.” - Key points The episode reframes age-related infertility as an energy problem Instead of only “biological clock” decline, the hosts argue fertility may be limited by mitochondrial energy capacity. The paper focuses on a high-risk fertility demographic Women ages 40–43, often labeled “poor prognosis,” with failed IVF and miscarriage histories. The headline result is striking In a small case series, the study reports 3 women treated, 3 live births (100%).The hosts correctly note this is a very small sample size—but still a strong signal. Egg cells are mitochondria-heavy Oocytes contain far more mitochondria than most other cell types because they require enormous energy for meiosis and chromosomal segregation. Mitochondrial decline may drive poor egg quality with age As mitochondrial function declines, ATP output drops and chromosomal errors increase.This contributes to aneuploidy, failed IVF, and miscarriage risk. PBM is presented as a mitochondrial “fuel injection” Red and near-infrared light stimulate cytochrome c oxidase, supporting ATP production and cellular energy. The treatment target is not just the ovaries The protocol treated: Lower abdomen (ovaries/uterus)Lower back/sacrum (nerve roots)Neck/cervical region + clavicular lymph nodes (brainstem/vagus influence)Gut/navel region (microbiome + estrogen metabolism) The “proximal priority theory” is a key concept Treating the neck may support the brain-hormone axis and vagus nerve, helping shift the body from stress mode to reproductive mode. The protocol used multi-wavelength PBM 660 nm red + near-infrared wavelengths (810/850/940 nm)Red supports superficial tissues; near-infrared penetrates deeper to reach pelvic structures. Case 1: recurrent miscarriage history → euploid embryos + live birth A 41-year-old with miscarriages/molar pregnancy produced multiple blastocysts, including two euploid embryos, and had a live birth at 42. Case 2: 4 failed IVF cycles → success after higher-frequency PBM PBM every 2–3 days during stimulation; a day-3 fresh transfer succeeded, suggesting improved uterine receptivity. Case 3: failed embryo transfer → natural conception after PBM After a difficult IVF course and failed transfer, she did a PBM protocol for natural conception and conceived naturally. Pregnancy safety was addressed cautiously During early pregnancy support, the protocol was modified: No abdominal treatmentFocus on cervical spine, lymph nodes, and feet The hosts discuss penetration depth and systemic support rather than direct fetal exposure. The larger thesis: fertility treatment often focuses on “software” Hormones/manipulation = softwareMitochondria/blood flow/cellular energy = hardwarePBM is presented as a hardware-first strategy. - Episode timeline 0:19–1:14 — Intro and paradigm shift setup The hosts challenge the “biological ...
    続きを読む 一部表示
    25 分
  • Can Light Really Heal Chronic Pain? The 2026 Review That Could Change Pain Treatment Forever

    Can Light Really Heal Chronic Pain? The 2026 Review That Could Change Pain Treatment Forever
    2026/02/21
    Chronic pain affects an enormous portion of the population and for decades, the default answers have been drugs, sedation, or invasive procedures. In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey unpack a 2026 systematic review (Ferreira et al.) that analyzed 14 randomized controlled trials on photobiomodulation (PBM) for chronic pain conditions, including fibromyalgia, neuropathy, TMJ/TMD, and post-COVID pain. They break down the “energy code” behind PBM: how red and near-infrared light can stimulate mitochondria to produce more ATP, lower inflammatory cytokines (like IL-1β, IL-6, and TNF-α), and modulate pain signaling in both peripheral nerves and the central nervous system. The episode also covers why PBM is not “just shining a flashlight,” why dosing and wavelength precision matter, and why this field may represent a shift from the chemical age of medicineto the energy age. Most importantly, they discuss the clinical implications: meaningful symptom relief, improved function and quality of life, and a remarkably strong safety profile—with 13 of 14 trials reporting zero adverse events. (Educational content only, not medical advice.) - Article Discussed in Episode: Photobiomodulation in chronic pain: a systematic review of randomized clinical trials - Key Quotes From Dr. Mike: “What if the answer (to chronic pain) wasn’t chemical at all? What if the answer was actually energetic?” “You’re making the world less hostile to their bodies.” (re: fibromyalgia pain threshold) “We’re talking about repairing the wiring, not just muting the signal.” “PBM doesn’t just numb the pain… it is returning the tissue to a functional state.” “We are moving from the chemical age to the energy age.” - Key points Chronic pain is a massive global problem The episode frames chronic pain as a major public health crisis, affecting a huge percentage of adults worldwide. PBM is not “flashlight therapy” This is a precise medical/biological intervention using specific wavelengths and dosing parameters—not generic red light. The episode centers on a 2026 systematic review Ferreira et al. analyzed 14 randomized controlled trials (2015–2025), making this one of the strongest summaries of recent PBM pain research. PBM works through a 3-pronged mechanism Mitochondrial boost (more ATP / “recharging the battery”) Inflammation reduction (lower IL-1β, IL-6, TNF-α, prostaglandins) Neural modulation (reduced pain fiber excitability + neurotransmitter shifts) Wavelength and power density are everything The biological “key” usually falls in the 660–905 nm range, with correct irradiance needed to trigger a mitochondrial response. Fibromyalgia results were especially encouraging The review highlighted rigorous trials (including triple-blinded designs) showing reduced tender points, lower pain, and improved pain threshold. Whole-body PBM may improve quality of life In addition to symptom reduction, some studies showed improvements in health-related quality of life, which matters deeply in chronic pain. Neuropathy outcomes were clinically meaningful Chemotherapy-induced neuropathy: notable response rates and reduced neuropathy scores Diabetic neuropathy: significant pain reductions using LED-based protocols PBM may help post-COVID pain syndromes The review included data on post-COVID orofacial pain and tension headaches, with reductions in pain scores and improvements in sleep/enjoyment of life. TMJ/TMD results suggest PBM is best as part of a plan PBM helped in some studies, but manual therapy sometimes performed similarly—supporting a multi-modalapproach. Safety is one of PBM’s strongest advantages 13 out of 14 trials reported zero adverse events; the only noted effects were mild/transient warmth or tingling. The big limitation: protocol heterogeneity Different wavelengths, doses, and treatment durations make standardization difficult—this is the “wild west” problem. PBM may restore function, not just reduce pain The review found improvements in walking, working ability, sleep, and daily functioning—not just lower pain scores. The larger theme: a shift to energy medicine The episode closes on the idea that medicine may be moving from a “chemical age” to an “energy age.” - Episode timeline 0:19–1:28 — Intro: chronic pain as a global crisis Don and Dr. Mike frame the scale of chronic pain and introduce the central question: can light treat pain? 1:28–2:40 — The review they’re unpacking (Ferreira, 2026) Overview of the systematic review in Frontiers in Integrative Neuroscience and its 14 RCTs. 2:40–3:34 — Skeptic question: “Is this just a flashlight?” They address the common misconception and define PBM as a real scientific modality. 3:34–6:59 — How PBM works: the 3-pronged mechanism Mitochondrial ATP boost Inflammation reduction Neural modulation Includes why 660–905 nm and irradiance matter. ...
    続きを読む 一部表示
    22 分
  • Your Thyroid Can “See” Blue Light — And a Wearable Patch Used It to Stop Thyroid Cancer

    Your Thyroid Can “See” Blue Light — And a Wearable Patch Used It to Stop Thyroid Cancer
    2026/02/20
    What if your thyroid gland isn’t just a chemical factory—but a light-sensing organ with the hardware to “see”? In this Energy Code Deep Dive, we unpack a jaw-dropping paper: “Wearable Photobiomodulation Halts Thyroid Cancer Growth by Leveraging Thyroid Photosensitivity.” The study suggests papillary thyroid carcinoma cells express opsins(photoreceptor proteins like those in the retina)—specifically a short-wavelength opsin tuned for blue light. Researchers ran a “wavelength war” (red vs green vs blue) and found 465 nm blue light uniquely halted cancer growth, first by cell-cycle arrest and then—inside living animals—by triggering apoptosis (cell self-destruction). Even wilder: they engineered a battery-free, NFC-powered wearable that delivered a precise dose over weeks, suppressing tumors while leaving thyroid hormone function intact. This episode reframes light as an instruction set—and asks the bigger question: are we “light malnourished” in a world spent indoors? (Educational content only, not medical advice.) - Article Discussed in Episode: Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity - Key Quotes From Dr. Mike: “They discovered the thyroid itself is a non-visual photoreceptive organ.” “The thyroid has a built-in antenna for blue light.” “We’ve been ignoring the optical anatomy of the human body.” “Light is an instruction set for the world inside of us.” “Maybe our internal organs are literally starving for the right kind of light.” - Key points The thyroid may be photoreceptive: thyroid cancer cells were found to contain opsins, the same class of light-sensing proteins used for vision. OPN1SW shows up in thyroid cancer: a short-wavelength opsin suggests the tissue is tuned to blue lightsignaling. PBMT ≠ PDT: photodynamic therapy requires injected dyes; photobiomodulation uses intrinsic biology—no photosensitizer needed. A “wavelength war” identified the winner: red (650 nm) and green (520 nm) did nothing; blue (465 nm) significantly inhibited proliferation. Mechanism in vitro: cell-cycle arrest: blue light trapped cells in G0/G1, increasing P21 (brake) and decreasing CDK4 (gas pedal). Dose matters: effects were dose-dependent, with an optimal 24-hour cycle delivering 172.8 J—“light is a drug.” Blue light penetration challenge addressed: in 3D tumor spheroids, the blue light still reduced tumor volume over 7 days. Real-world delivery required engineering: a thin wireless wearable patch powered by NFC (tap-to-pay tech) delivered therapy without a battery. In vivo effect: apoptosis: in mice, tumors didn’t just pause—they underwent programmed cell death. Why dish vs body differs: possible “endogenous photosensitizers” generated by metabolism and/or immune involvement in living systems. Safety profile stood out: thyroid hormones (T3/T4) remained stable; no weight loss; no liver/kidney toxicity markers. Paradigm shift: suggests a future of organ-preserving, non-invasive metabolic/energetic medicine—and expands the idea that organs may be energy “antennas.” - Episode timeline 0:19–1:16 — Hook: organs that can “see” The thyroid as a light-sensing organ; intro to the study and why it matters. 1:16–3:16 — Thyroid cancer + why current treatment is brutal Papillary thyroid carcinoma prevalence; “good cancer” myth; thyroidectomy/radioiodine tradeoff and lifelong hormone dependence. 3:16–4:08 — PDT vs PBMT Why this isn’t lasers or dye-based photodynamic therapy; PBMT uses intrinsic cellular “hardware.” 4:08–5:29 — The smoking gun: opsins in thyroid cancer Non-visual photoreception; opsins in thyroid tissue; OPN1SW implies blue-light sensitivity. 5:29–7:33 — The ‘wavelength war’ + mechanism 650 red / 520 green / 465 blue; blue inhibits proliferation via G0/G1 arrest; P21 up, CDK4 down. 7:33–8:23 — Dose precision: Arndt–Schulz law Light as a dose-dependent medicine; optimal 172.8 J over a 24-hour cycle. 8:23–9:17 — The penetration skeptic test 3D tumor spheroids; tumor volume shrinks over 7 days—blue can work in 3D at correct intensity. 9:17–10:27 — Wearable engineering solution Battery-free, flexible, wireless blue LED patch; NFC-powered; biocompatible coating. 10:27–12:05 — In vivo results: from “pause” to “kill” 21-day mouse study: tumors suppressed; apoptosis in living system; endogenous photosensitizers and/or immune assist hypothesis. 12:05–13:22 — The safety miracle No collateral damage; T3/T4 stable; no systemic toxicity markers. 13:22–14:28 — Big implications Non-invasive organ-preserving cancer therapy; opens question of other light-sensitive organs. 14:28–15:24 — Recap: 3 key takeaways Body as light receiver; specificity of 465 nm + dose; wearables make it practical now. 15:24–16:26 — Final thought: “light malnourished” If thyroid expects ...
    続きを読む 一部表示
    17 分
  • Your Mitochondria Aren’t “Powerhouses” — They’re a Living, Networked Operating System (And We Can Hack It)

    Your Mitochondria Aren’t “Powerhouses” — They’re a Living, Networked Operating System (And We Can Hack It)
    2026/02/19
    Most people think mitochondria are just tiny “powerhouses.” In this deep dive, Dr. Mike Belkowski breaks that outdated meme wide open by portraying mitochondria as a dynamic, shape-shifting power grid that talks to your nucleus, runs cellular quality control, and can even transfer between cells like an organelle transplant. Using a major 2025 review on mitochondrial diseases and therapeutic advances as the roadmap, we unpack the real mechanics of energy production (the “hydroelectric dam” of oxidative phosphorylation), why mitochondrial DNA is uniquely vulnerable, how dysfunctional mitochondria can trigger chronic inflammation, and why tools like exercise and light aren’t wellness trends — they’re direct inputs into your energy hardware. Then we go full sci-fi (but real): gene therapy, “three-parent babies,” precision editing of mitochondrial mutations, and the emerging possibility of mitochondrial transfer as a future regenerative therapy. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondrial diseases: from molecular mechanisms to therapeutic advances - Key Quotes From Dr. Mike: “That powerhouse meme is so outdated—it’s like calling a supercomputer a calculator.” “Mitochondria are a constantly moving, dynamic network… like a mobile power grid.” “You breathe so oxygen can be the trash can for electrons at the end of the line.” “Fusion is a rescue mission. Fission is quarantine.” “You can swallow all the anti-inflammatory supplements you want—but if the pipe is still burst, you’re just mopping the floor.” - Key points Mitochondria are dynamic networks, not static beans—they fuse, split, move, and deliver energy where it’s needed. They’re “alien” in origin: mitochondria evolved from bacteria that formed a symbiotic relationship with early cells. You run on two genetic systems: nuclear DNA + mitochondrial DNA (mtDNA), and mtDNA is far more exposed to damage. mtDNA is vulnerable by design—it lacks histone “armor” and sits next to the ROS-producing “furnace.” Mitochondria require constant nuclear support: mtDNA encodes a tiny fraction of needed proteins; most are built in the nucleus and imported via the TOM/TIM “mailroom.” Mitochondria talk back via mitochondrial-derived peptides (ex: MOTS-c) that can influence gene expression. Energy production is mechanical: electron transport pumps protons to build a gradient that drives ATP synthaselike a turbine. Supercomplexes improve efficiency and reduce “dropped electrons” (free radicals). Quality control is built-in: fusion rescues; fission isolates damage; PINK1/Parkin flags failing mitochondria for mitophagy; MDVs prune small defects. Mitochondria can trigger inflammation: severe damage can spill mtDNA and activate immune alarm pathways—fueling chronic “inflammaging.” Disease depends on heteroplasmy: you can carry mutations and remain healthy until a threshold of “bad copies” is reached in high-energy tissues. Light is a mitochondrial input: red/NIR can support energy machinery, while high-energy blue light can be a stressor—especially in vulnerable tissues. Repair is becoming real: bypass drugs, peptides that stabilize membranes, lifestyle upgrades (exercise → PGC-1α), and frontier therapies like gene transfer and mtDNA editing. - Episode timeline 0:00–0:38 — Opening + mission The Energy Code premise: decode mitochondria to build “limitless vitality.” 0:38–2:20 — The myth: mitochondria aren’t just powerhouses Why the “kidney bean” model is obsolete—and what the 2025 review changes. 2:20–4:47 — Origin story: the ‘alien’ inside you Endosymbiosis + why mitochondria have their own DNA. 5:00–7:18 — mtDNA: the fragile code behind aging No histone protection, proximity to ROS, high mutation rate, maternal inheritance. 7:32–9:11 — Nuclear ↔ mitochondrial logistics Why mitochondria need 1000+ proteins; TOM/TIM import system and “zip codes.” 9:22–10:21 — Messages from the power plant Mitochondrial-derived peptides (ex: MOTS-c) as whole-body metabolic regulators. 10:25–14:16 — The operating system: OXPHOS explained Hydroelectric dam analogy, ETC complexes, ATP synthase turbine, oxygen as terminal acceptor; supercomplexes reduce free radicals. 14:27–17:36 — Quality control: fusion, fission, mitophagy, MDVs Rescue vs quarantine; PINK1/Parkin “condemned sign”; targeted pruning. 17:48–18:58 — The sci-fi reality: mitochondria transfer between cells Tunneling nanotubes, rescue donations, and garbage handoffs. 19:00–24:35 — Mitochondrial diseases + heteroplasmy threshold Why symptoms hit high-energy tissues first; examples: LHON, MELAS, Barth syndrome; cardiolipin as “glue” for supercomplexes. 24:41–27:19 — ROS + the inflammation connection ROS as signaling vs chronic overload; mtDNA leakage, immune alarms, inflammaging. 27:33...
    続きを読む 一部表示
    37 分